ReviewNeurology. Clinical practice2019
"Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.
Review in Neurology. Clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- Management of Anxiety in Parkinson's Disease.Movement disorders clinical practice · 2025Pooled it
- Caregiver burden of parkinsonian patients with impulse control disorders, depression and apathy.Journal of neural transmission (Vienna, Austria : 1996) · 2026Article
- Geriatric Depression Mimicking Parkinson's Disease: A Case of Levodopa-Responsive Pseudoparkinsonism With a 3-Year Follow-Up.Clinical case reports · 2026Article
- Differentiating Treatment-Resistant Depression With and Without Parkinsonism in the Elderly From a Psychiatric Perspective byInternational journal of geriatric psychiatry · 2025Article
- Neuropsychiatric disorders in Parkinson's disease.Therapeutic advances in neurological disorders · 2025Review
- Biomarkers and Rehabilitation for Functional Neurological Disorder.Journal of personalized medicine · 2024Review
- Treatment of Apathy in Parkinson's Disease and Implications for Underlying Pathophysiology.Journal of clinical medicine · 2024Review
- Article
- The experience of Anxiety for people with Parkinson's disease.NPJ Parkinson's disease · 2023Article
- Apathy in Parkinson's Disease: Defining the Park Apathy Subtype.Brain sciences · 2022Review
- Mind the gap: Inequalities in mental health care and lack of social support in Parkinson disease.Parkinsonism & related disorders · 2021Review
- The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.Current psychiatry reports · 2021Review
- Deconstructing Apathy in Parkinson's Disease: Challenges in Isolating Core Components of Apathy From Depression, Anxiety, and Fatigue.Frontiers in neurology · 2021Article
- ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease.Journal of Parkinson's disease · 2021Article
- Computational Modeling for Neuropsychological Assessment of Bradyphrenia in Parkinson's Disease.Journal of clinical medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewPhysicians treating patients with Parkinson disease must evaluate not only motor symptoms but also acquire expertise in assessing the complex behavioral features that often accompany the disease, such as dementia, apathy, anxiety, and depression. RECENT
findingsThere is a risk of diagnostic confusion and error because many of the behavioral and motor symptoms accentuate, overlap, or mimic each other. SUMMARY: Awareness of potential diagnostic pitfalls and "pseudo-syndromes" should lead to more accurate clinical assessment and better care for our patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.